Tag: SIXW.C
-
Sixth Wave (SIXW.C) completes DFM and begins delivery of first Affinity System to AESI
Sixth Wave Innovations (SIXW.C) announced that they have completed the initial Design for Manufacturing (DFM) of their Affinity System. They also announced that they commissioned the delivery of the first system to Advanced Extraction Systems Inc. (AESI) in Charlottetown, PEI, and has given AESI approval of the design and bill of materials. The Affinity system…
-
Sixth Wave Innovations (SIXW.C) Enters LOI With Halucenex Life Sciences
Sixth Wave Innovations (SIXW.C) entered into a non-binding letter of intent (LOI) with Halucenex Life Sciences, a soon to be wholly-owned subsidiary of Cresco Pharma. According to the terms outlined in the LOI, Sixth Wave will utilize its Affinity™ in collaboration with Halucenex to explore the separation of compounds such as psilocybin, baeocystin, and others…
-
Sixth Wave (SIXW.C) surges 15% as Polymer Imprint detects SARS-CoV-2 during initial testing
“Molecularly imprinted polymers (MIPs) are synthetic polymers with a predetermined selectivity for a given analyte, or group of structurally related compounds, making them ideal materials to be used in separation processes,” explains Science Direct.
-
Sixth Wave (SIXW.C) partners with super-star research institution – potential pipeline accelerator
Dr. Houghton – a Director and Research Chair holder at Li Ka Shing – just won a Nobel Prize.
-
Sixth Wave (SIXW.C) gets $250,000 Covid-19 development money from Nova Scotia
SIXW is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs).
-
How Sixth Wave (SIXW.C) plans to “protect and detect” for COVID-19
Sixth Wave is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs).